http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105177025-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-37 |
filingDate | 2014-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105177025-B |
titleOfInvention | Type 18 recombinant human papillomavirus virus-like particle and preparation method thereof |
abstract | The invention relates to type 18 recombinant human papillomavirus virus-like particles and a preparation method thereof, and the specific technical points are to provide a new polynucleotide gene fragment encoding a recombinant HPV118 L1 protein, a vector comprising the gene fragment, and a vector including the vector Host cells, as well as the HPV118 L1 fusion protein, pentamer and VLP composed of the pentamer translated and expressed by the gene fragment, the present invention also discloses that the pentamer, the VLP protein and the vaccine composition composed of the pentamer are used in the preparation of prevention Drug application in HPV118 infection. |
priorityDate | 2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 671.